Liver Disease Diagnosis And Treatment
83 researchers across 8 institutions
Research in liver disease diagnosis and treatment explores the underlying mechanisms of liver pathologies and the development of novel therapeutic strategies. Investigations encompass understanding disease progression, identifying biomarkers for early detection, and evaluating the efficacy of pharmacological and non-pharmacological interventions. Methodologies include molecular biology techniques, advanced imaging, and clinical studies to assess patient outcomes. Specific areas of focus include viral hepatitis, alcoholic and non-alcoholic fatty liver disease, autoimmune liver conditions, and drug-induced liver injury.
This work holds significant relevance for Arkansas, addressing public health challenges related to prevalent liver conditions and contributing to the state's growing biosciences sector. Understanding the environmental and lifestyle factors that contribute to liver disease in the state informs public health initiatives and potential economic development in areas such as diagnostics and therapeutics. The research also considers the unique demographic and health profiles within Arkansas, aiming to develop accessible and effective treatments.
This field of study draws upon expertise from related disciplines including metabolism, genetics, immunology, pharmacology, and cancer research. Collaborations extend across multiple Arkansas higher education institutions, fostering a comprehensive approach to tackling complex liver diseases.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Igor P. Pogribny | NCTR | 75 | 17,950 | ARA High Impact | |
| Mitchell R. McGill | UAMS | 45 | 9,594 | Grant PI High Impact | |
| Soheila Korourian | UAMS | 44 | 5,439 | High Impact | |
| Qiang Shi | NCTR | 37 | 16,849 | High Impact | |
| Qingsu Xia | NCTR | 35 | 5,384 | High Impact | |
| Gonçalo Gamboa da Costa | NCTR | 31 | 2,761 | High Impact | |
| Marion Rowland | University of Arkansas | 30 | 3,669 | High Impact | |
| Charles W. Miller | University of Arkansas | 29 | 3,396 | High Impact Grants | |
| Brian D. Piccolo | UAMS | 24 | 1,799 | High Impact | |
| Reza Hakkak | UAMS | 24 | 1,864 | High Impact | |
| Kelly E. Mercer | NCTR | 24 | 3,453 | High Impact | |
| Eric U. Yee | UAMS | 22 | 1,556 | High Impact | |
| Jeffery T. Walker | UA Little Rock | 19 | 1,352 | ||
| Ragesh B. Thandassery | UAMS | 18 | 1,017 | ||
| Amjid Riaz | University of Arkansas | 16 | 857 | ||
| J. Hanks | NCTR | 15 | 970 | ||
| Adriana Lelis Carvalho | UAMS | 14 | 541 | ||
| Roopa Ram | UAMS | 13 | 436 | ||
| Fazal Karim | UA Pine Bluff | 13 | 672 | ||
| Sanaz Ameli | UAMS | 13 | 375 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Liver Disease Diagnosis And Treatment in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
- Cancer Treatment and Pharmacology
- Organ Transplantation Techniques and Outcomes
- Cardiovascular Function and Risk Factors
- SARS-CoV-2 and COVID-19 Research
- Health Literacy and Information Accessibility
- Pancreatic and Hepatic Oncology Research
- Nanoparticles: synthesis and applications
- Meta-analysis and systematic reviews
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 3,537
- 2 University of California, San Francisco 2,400
- 3 University of California San Diego 2,390
- 4 Mayo Clinic 2,351
- 5 Johns Hopkins University 2,317
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Liver Disease Diagnosis And Treatment.